By Naresh Kusi The Himalayan wolf (Canis lupus chanco) and snow leopard (Panthera uncia) are apex predators in alpine ...
Mesoblast shares fall ~7% despite a $260 million placement following FDA approval for its cell therapy treatment ...
The Mesoblast Ltd (ASX: MSB) share price is catching the eye of investors on Tuesday. Why are its shares being hammered?
On Dec. 19, Mesoblast announced the U.S. Food and Drug Administration (FDA) approved Ryoncil. Ryoncil is the first FDA ...
The biotech company requested a trading halt before the market open on Friday. Here's why. The post Why are Mesoblast shares ...
Mesoblast’s achievement in winning approval for its Ryoncil drug in the US in December heralds the arrival of a new class of ...
Mesoblast stock climbs 80% in a month following the FDA's approval of Ryoncil as the only approved therapy for SR-aGVHD in children aged two months and older.
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore 637371, Singapore ...
Eating or limiting other foods may also help, but research is ongoing. Share on Pinterest Nadine Greeff/Stocksy United Parkinson’s disease affects nearly 1 million people in the United States ...